Tech Company Financing Transactions
Xcovery Vision Funding Round
Betta Pharmaceuticals participated in a $20 million funding round for Xcovery Vision. The round was announced on 10/30/2014.
Transaction Overview
Company Name
Announced On
10/30/2014
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Betta Pharmaceuticals (Fenlai Tan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
155 Gibbs St. 427
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Xcovery Vision is leading translational research efforts to develop novel treatments for eye disease by leveraging knowledge gained from Xcovery's oncology drug programs. Xcovery Vision has an exclusive license to develop Xcovery's novel kinase inhibitors for use in the field of ophthalmology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Richman
VP - Bus. Development
Daniel Salazar
Browse more venture capital transactions:
Prev: 10/30/2014: Medipacs venture capital transaction
Next: 10/30/2014: uBeam venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs